A diverse group of researchers and diagnostic industry participants has collaborated to produce two papers that describe and critique Lyme disease testing technologies.
The test, which uses lateral flow immunochromatographic technology, demonstrated high accuracy in a recent study and is being planned for a submission to the FDA.
Dendritics develops antibodies against immune system and other cells for the discovery of targets with high diagnostic, prognostic, and therapeutic potential.
